Ontology highlight
ABSTRACT:
SUBMITTER: Dobish MC
PROVIDER: S-EPMC3528807 | biostudies-literature | 2012 Dec
REPOSITORIES: biostudies-literature
Organic letters 20121207 24
VNI is a potent inhibitor of CYP51 and was recently shown to achieve a parasitological cure of mice infected with T. cruzi in both acute and chronic stages of infection. T. cruzi is the causative parasite of Chagas disease, a neglected tropical disease. The first enantioselective chemical synthesis of VNI (at a materials cost of less than $0.10/mg) is described. Furthermore, the key enantioselective step is performed at the 10 g scale. ...[more]